May 17, 2021
B.Optom (Hons), MBBS (Hons), MPH (Hons), FRANZCO
Dr Michael Chilov is an ophthalmologist with subspecialty interests in cataract surgery and retinal/macular conditions.
After completing a Bachelor of Optometry degree at UNSW, he went on to study Medicine at the University of Sydney. He then undertook fellowship training in ophthalmology at Sydney Eye Hospital and Bristol Eye Hospital in the UK.
Dr Chilov is an experienced cataract surgeon performing hundreds of cataract operations every year. He uses the latest technologies in his surgery and stays abreast of the new advances in treatment by attending and speaking at major international meetings. He is a member of the American Society of Cataract and Refractive Surgeons (ASCRS).
Dr Chilov has extensive experience in the management of retinal and macula conditions. He is involved in a number of international clinical trials investigating the latest treatments for macular degeneration, diabetic retinopathy and retinal vein occlusion and is able to bring this knowledge to his patients. He has written a number of peer-reviewed publications and regularly reviews journal articles that have been submitted for publication. He is a member of the Australian and New Zealand Society of Retinal Specialists (ANZSRS) and American Society of Retinal Specialists (ASRS).
Dr Chilov is a consultant at two of Sydney’s largest ophthalmic teaching hospitals, Concord and Sydney Eye Hospital, where he is actively involved in the training of the next generation of eye surgeons. He performs surgery at leading accredited ophthalmic surgery centres, public and private hospitals and is supported by a team of skilled anaesthetists.
Dr Chilov is focussed on achieving the best possible visual outcomes for his patients. He takes time to understand your visual requirements and discusses the various options that are available to you.
Bruce Bennett says new technology that zeroes in on hard-to-target prostate cancer is a great advancement – he just wishes it had arrived earlier, and cheaper. After three biopsies, dating back to 2005, that missed his cancer, Bennett – a 65-year-old retired Wellington teacher – was tested earlier this year with new fusion biopsy technology, which found […]
Read moreAcurity Health Group and property partner Vital Healthcare Property Trust have confirmed base isolators will be employed in the $106 million re-development of Wellington’s Wakefield Hospital enabling it to remain operational after a major earthquake. Wellington City Council has granted a Resource Consent for the proposed new hospital. Enabling works are currently underway with construction expected […]
Read moreBase isolators will be part of Wakefield Hospital’s $106 million redevelopment to ensure it can keep operating following a major earthquake. Plans were announced in November to bowl most of Wellington’s largest private hospital, in Newtown, to make way for an upgrade which will give patients access to state-of-the art facilities. Acurity Health Group and property partner Vital […]
Read more